Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Issues
2016
April 2016, Vol 7, No 3
April 2016, Vol 7, No 3
Biomarker for Uveal Melanoma Has Immediate Clinical Impact
By
Phoebe Starr
Personalized Medicine
April 2016, Vol 7, No 3
A new biomarker can identify the subgroup of class 1 uveal melanomas that are most likely to metastasize, according to a new retrospective study (Field MG, et al.
Clin Cancer Res
. 2016;22:1234-1242).
Read Article
Genomics May Explain Poor Survival of African Americans with Kidney Cancer
By
Phoebe Starr
Personalized Medicine
April 2016, Vol 7, No 3
Differences in 3 recently identified molecular factors in patients with metastatic renal-cell carcinoma (RCC) may explain the inferior survival rates in African-American patients versus in Caucasian patients, even in the age of targeted therapy.
Read Article
Improving Value by Understanding the Total Cost of Cancer Care
By
Meg Barbor, MPH
Value in Oncology
April 2016, Vol 7, No 3
The use of cost data to inform infrastructure investments can help cancer centers move toward value-based payment models, improve end-of-life planning, and reduce futile care, according to Kerin B. Adelson, MD, Chief Quality Officer and Deputy Chief Medical Officer, Smilow Cancer Hospital (SCH) at Yale-New Haven, CT.
Read Article
Oncology Biosimilars: Opportunity or Not?
By
Martha M. Rumore, PharmD, JD, MS, LLM, FAPhA
;
F. Randy Vogenberg, PhD, RPh, FASHP
Employers’ Perspective
,
Value Peer-spectives
,
Biosimilars
April 2016, Vol 7, No 3
The United States has the largest biologic drugs market and high prices for biologics, such as monoclonal antibodies, therapeutic proteins, immunomodulators, and growth factors. Cancer treatments utilize traditional chemical-based drugs and, increasingly, biologic-based drugs.
Read Article
In the Literature - April 2016
In the Literature
April 2016, Vol 7, No 3
Read Article
FDA News - April 2016
FDA Approvals, News & Updates
April 2016, Vol 7, No 3
Read Article
Oncology News - April 2016
Oncology News
April 2016, Vol 7, No 3
Read Article
Transplant Remains Best Upfront Treatment Option in Newly Diagnosed Myeloma
By
Dana Taylor
Hematologic Malignancies
April 2016, Vol 7, No 3
The use of novel agents in multiple myeloma has led experts to question whether autologous stem-cell transplant (ASCT) is warranted upfront, or whether it can be used as effectively after patients relapse.
Read Article
Cost of Care Not Linked to Improved Survival for Elderly Patients with Myelodysplastic Syndromes
By
Chase Doyle
Value in Oncology
April 2016, Vol 7, No 3
A study of state-specific costs of care and survival among Medicare beneficiaries with myelodysplastic syndromes (MDS) shows no correlation between the cost of care and patient outcomes.
Read Article
Improving Survivorship Care: A Patient Advocate's Prescription
By
Chase Doyle
Survivorship
,
Policies & Guidelines
April 2016, Vol 7, No 3
The job of the oncology medical team is to put out the fire, stop the emergency, and save the patient’s life, said Diane Heditsian, Researcher and Patient Advocate, Breast Oncology Program, University of California, San Francisco, during the 2016 Cancer Survivorship Symposium.
Read Article
Page 2 of 3
1
2
3
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma